FDA Approved: ENBUMYST — Original Application (Corstasis USA LLC)

View source ↗

Summary

The FDA approves ENBUMYST (bumetanide) from Corstasis USA LLC via its Original Application (NDA219500).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Liver Cirrhosis
• Nephrotic Syndrome

Drugs mentioned

• ENBUMYST (BUMETANIDE)

Snippet

ORIG AP for ENBUMYST (BUMETANIDE)